Abstract
An-Wen Chan discusses the implications of a new study inPLoS Medicine that suggests that the randomized trial literature is skewed towards reporting favorable results.
MeSH terms
-
Bias
-
Drug Approval / statistics & numerical data*
-
Humans
-
Mandatory Reporting*
-
Publication Bias*
-
Randomized Controlled Trials as Topic / statistics & numerical data*
-
United States
-
United States Food and Drug Administration*